AKESF
Price
$12.40
Change
+$0.52 (+4.38%)
Updated
Jun 24 closing price
Capitalization
10.58B
ALGS
Price
$7.21
Change
+$0.07 (+0.98%)
Updated
Jun 27 closing price
Capitalization
44.09M
Interact to see
Advertisement

AKESF vs ALGS

Header iconAKESF vs ALGS Comparison
Open Charts AKESF vs ALGSBanner chart's image
AKESO
Price$12.40
Change+$0.52 (+4.38%)
Volume$518
Capitalization10.58B
Aligos Therapeutics
Price$7.21
Change+$0.07 (+0.98%)
Volume$87.52K
Capitalization44.09M
AKESF vs ALGS Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. ALGS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and ALGS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AKESF: $12.40 vs. ALGS: $7.21)
Brand notoriety: AKESF and ALGS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 9% vs. ALGS: 62%
Market capitalization -- AKESF: $10.58B vs. ALGS: $44.09M
AKESF [@Biotechnology] is valued at $10.58B. ALGS’s [@Biotechnology] market capitalization is $44.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileALGS’s FA Score has 1 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • ALGS’s FA Score: 1 green, 4 red.
According to our system of comparison, AKESF is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 4 TA indicator(s) are bullish while ALGS’s TA Score has 5 bullish TA indicator(s).

  • AKESF’s TA Score: 4 bullish, 3 bearish.
  • ALGS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AKESF is a better buy in the short-term than ALGS.

Price Growth

AKESF (@Biotechnology) experienced а +7.00% price change this week, while ALGS (@Biotechnology) price change was -4.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKESF($10.6B) has a higher market cap than ALGS($44.1M). AKESF YTD gains are higher at: 77.143 vs. ALGS (-81.903).
AKESFALGSAKESF / ALGS
Capitalization10.6B44.1M24,036%
EBITDAN/A-83.89M-
Gain YTD77.143-81.903-94%
P/E Ratio25.37N/A-
RevenueN/A3.27M-
Total CashN/A138M-
Total DebtN/A7.87M-
TECHNICAL ANALYSIS
Technical Analysis
AKESFALGS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
36%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEP131.042.82
+2.20%
PepsiCo
GHM50.570.74
+1.49%
Graham Corp
LBTYB9.60N/A
N/A
Liberty Global Ltd
TURN3.96-0.04
-0.89%
180 Degree Capital Corp
ADV1.31-0.03
-2.24%
Advantage Solutions

AKESF and

Correlation & Price change

A.I.dvisor tells us that AKESF and LGVN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKESF and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
N/A
LGVN - AKESF
24%
Poorly correlated
+1.54%
BNTX - AKESF
24%
Poorly correlated
+0.55%
EVAX - AKESF
23%
Poorly correlated
-5.41%
ALGS - AKESF
21%
Poorly correlated
+0.98%
AURX - AKESF
20%
Poorly correlated
N/A
More

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+0.98%
XNCR - ALGS
40%
Loosely correlated
-3.10%
RLAY - ALGS
37%
Loosely correlated
-0.60%
CRNX - ALGS
34%
Loosely correlated
-0.10%
RZLT - ALGS
32%
Poorly correlated
+0.93%
ARWR - ALGS
32%
Poorly correlated
+0.06%
More